MARKER THERAPEUTICS INC (MRKR) Stock Income Statement
NASDAQ:MRKR - Nasdaq - US57055L2060 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.70M | 6.59M | 3.31M | 9.01M | 1.24M | |||
| Operating Expenses | 18.42M | 17.71M | 17.89M | 38.96M | 40.72M | |||
| Research and Development | 14.03M | 13.47M | 10.42M | 26.14M | 27.79M | |||
| Selling, General, and Administrative Expenses | 4.39M | 4.24M | 7.48M | 12.82M | 12.92M | |||
| Operating Income | -12.72M | -11.12M | -14.58M | -29.95M | -39.47M | |||
| Interest Income/Expense | 443.40K | 437.00K | 539.20K | 250.00K | 10.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 0.00 | -230.00K | -2.41M | |||
| Income Before Taxes | -12.73M | -10.68M | -14.04M | -29.93M | -41.88M | |||
| Income Tax | N/A | 50.00K | 3.70K | N/A | N/A | |||
| Net Income | -12.78M | -10.73M | -8.24M | -29.93M | -41.88M | |||
| EBITDA | N/A | N/A | N/A | -27.16M | -37.32M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.32 | -1.20 | -0.93 | -3.58 | -5.47 | |||
| Non GAAP EPS | -1.29 | -1.20 | N/A | -3.58 | -3.86 | |||
| Statistics | ||||||||
| Profit Margin | -224.45% | -162.82% | -248.76% | -332.19% | -3377.42% | |||
| Operating Profit Margin | -223.40% | -168.69% | -440.38% | -332.41% | -3183.06% | |||
All data in USD